The assessment of causation for a potential ... It is unclear just how the Naranjo scale came to be accepted as a tool to assist in the evaluation of drug interaction causation, but it is ...
IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today announced its second FDA authorization, securing 510(k) clearance from the U.S. Food and Drug Administration ...
It can help identify people at risk of Alzheimer's disease and screen for conditions like Parkinson's disease, brain tumors, substance abuse, and head trauma ... There are advantages and disadvantages ...